Prostacyclin, also known as prostaglandin I2, is a lipid-derived hormone involved in vascular homeostasis, platelet regulation, endothelial signaling, and blood flow control. PGI2 is one of the most important endogenous vasodilatory prostaglandins and functions as a counterbalance to platelet-activating and vasoconstrictive pathways within the cardiovascular system.
The hormone inhibits platelet aggregation, relaxes vascular smooth muscle, and helps maintain healthy blood vessel responsiveness. Prostacyclin also contributes to endothelial protection, regulation of pulmonary circulation, and modulation of inflammatory signaling within vascular tissues. Through these actions, PGI2 plays a central role in maintaining blood fluidity and coordinated vascular adaptation.
PGI2 is synthesized primarily by endothelial cells lining blood vessels. Production begins with phospholipase A2-mediated release of arachidonic acid from membrane phospholipids. Cyclooxygenase enzymes convert arachidonic acid into prostaglandin H2 intermediates, which are then converted into prostacyclin by prostacyclin synthase.
Because prostacyclin is unstable and short-lived, it acts mainly near its site of production. Endothelial tissues continuously generate small amounts to help maintain vascular equilibrium, while production can increase substantially during shear stress, vascular stimulation, or inflammatory signaling.
PGI2 production is regulated by endothelial activation, blood flow dynamics, inflammatory mediators, oxidative stress, nitric oxide signaling, and phospholipase activity. Mechanical forces generated by blood flow can stimulate endothelial prostacyclin synthesis to support vascular relaxation and circulation.
PGI2 acts through IP receptors that activate cyclic AMP pathways in platelets and vascular smooth muscle cells. These signaling systems reduce platelet aggregation and promote vasodilation. Local degradation pathways rapidly terminate signaling to preserve tissue specificity and cardiovascular balance. Through these integrated lipid-signaling and endothelial regulatory systems, prostacyclin coordinates vascular tone, platelet function, endothelial communication, and circulatory homeostasis.
Endothelium-derived eicosanoid that raises cAMP via IP receptors to dilate vessels and strongly inhibit platelet aggregation, supporting vascular homeostasis.
